Business Wire

INTELECY

Share
Yara Makes Strategic Investment in Industrial AI Company Intelecy

Intelecy has raised 3.5 mill USD in an investment round led by Yara, with participation from GC Rieber, Aidiom, and Investinor. Intelecy provides a no-code AI platform specifically tailored for industrial engineers and plant operators, eliminating the need for manual coding. By utilizing the platform, process engineers can rapidly create AI models to optimize processes that reduce waste, emissions, energy consumption and costs.

Intelecy serves customers in the chemicals, energy, food and beverages, mining and minerals, and utilities industries.

“Intelecy has developed exciting AI solutions for production and process optimization. We have received very strong recommendations from Intelecy’s industrial customers. Yara invests in Intelecy since we consider it a strategic priority to participate in the development of AI for the industry”, says Ulf Berg, SVP Portfolio Development in Yara International ASA and chair of the board at Yara Growth Ventures.

Intelecy is satisfied with having Yara as a new lead investor:
“Yara is the world’s leading crop nutrition company and a global provider of environmental and agricultural solutions. We consider the investment from Yara Growth Ventures a great validation of our vision, which is to help factory workers make industrial production more sustainable by optimizing production, reducing waste and energy consumption, and eliminating harmful emissions”, says Bertil Helseth, CEO of Intelecy and founder.

The industrial group GC Rieber also joined the investment round. GC Rieber is a customer of Intelecy and uses AI to optimize and digitalize the production of nutraceuticals.

“Our local factory workers use Intelecy to optimize the production of high-end omega-3 concentrates and to develop critical digital skills as part of the process. Intelecy has enabled us to embrace AI, making the factory smart and production more sustainable. We are very impressed by the ease-of-use of the Intelecy solution”, says Fredrik Harloff, CIO at GC Rieber.

Advances in AI represent a huge value-creation potential for the process industry. But many AI projects still fail. Industry leaders often cite a lack of talent as the critical barrier to adopting AI.

“We invest because Intelecy helps solving the skills gap in manufacturing by enabling the existing workforce to use AI”, says Jon Øyvind Eriksen, CEO at Aidiom and the chair of the board at Intelecy.”

Investinor increased its ownership stake in Intelecy.

“At Investinor, we’re investing in the businesses of tomorrow, and few sectors hold as much promise as artificial intelligence and machine learning. Intelecy stands out in the industrial AI space by offering businesses easily implementable tools for optimizing efficiency. Intelecy is well-positioned to meet the growing demand for intelligent and sustainable manufacturing solutions”, says Investment Manager Egil Garberg at Investinor.

The new funding will be used to strengthen marketing, sales, and product development. Erkki Altonen, CEO of Yara Growth Ventures, and Egil Garberg, investment director of Investinor, join the board of directors.

About Intelecy
Intelecy is a Norwegian SaaS company that was established with one clear goal: enabling sustainable production within the industry. Intelecy’s no-code Industrial AI platform is built for industrial data and made for industrial citizens. The easy-to-use tools enables engineers to create and use sophisticated AI models, without prior knowledge of coding. By using Intelecy, a wide range of industrial companies improve resource utilization, prevent unplanned downtime, increase capacity and minimize their environmental impact.

About Yara

About GC Rieber

About Aidiom

About Investinor

Intelecy newsroom: https://www.intelecy.com/post/yara-invests-in-intelecy

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230627066496/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Rimini Street Announces Upcoming 2025 Investor Conference Schedule15.5.2025 22:51:00 CEST | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that Michael L. Perica, chief financial officer, and Dean Pohl, vice president, treasurer and investor relations, will be presenting and meeting with investors one-on-one and in small group meetings at the following conferences: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515374696/en/ Rimini Street Announces Upcoming 2025 Investor Conference Schedule May 28, 2025: Craig-Hallum 22nd Annual Institutional Investor Conference, Minneapolis May 29, 2025: TD Cowen 53rd Annual TMT Conference, New York City Fireside Chat: 1:15 pm Eastern, webcast link June 24-26, 2025: Roth 15th Annual London Conference, London To schedule a meeting please contact your salesperson or Rimini Street Investor Relations at IR@rimin

Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States15.5.2025 20:30:00 CEST | Press release

Zynyz® (retifanlimab-dlwr), a PD-1 inhibitor, is now approved for the treatment of advanced squamous cell carcinoma of the anal canal (SCAC) in combination with chemotherapy and as a monotherapyPatients with SCAC treated with Zynyz achieved a statistically significant improvement in progression-free survival and improvement in overall survival Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz® (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC). In addition, the FDA granted approval for Zynyz as a single agent for the treatment of adult patients with locally recurrent or with metastatic SCAC with disease progression on or intolerance to platinum-based chemotherapy. Thi

DDC Announces Record 2024 Growth and Strategic Bitcoin Reserve Initiative in Shareholder Letter by Founder & CEO Norma Chu15.5.2025 20:23:00 CEST | Press release

DDC Enterprise Ltd. (NYSEAM: DDC), today released its 2024 full year results alongside a Shareholder Letter from Founder, Chairwoman, and CEO Norma Chu, underscoring the company’s positive financial performance and unveiling a pioneering Bitcoin accumulation strategy poised to redefine long-term value creation. To Our Valued Shareholders, 2024 was a year of transformative growth and strategic milestones for DDC. I am thrilled to share that we not only met our financial forecasts but exceeded expectations, delivering strong performance across key metrics while laying the groundwork for an even more exciting future. As we enter 2025, our momentum is accelerating, driven by disciplined execution and a bold new chapter in our corporate strategy. 2024 Financial & Operational HighlightsRevenue Growth: USD 37.4 million, a 33% year-over-year increase, propelled by the strategic acquisition of U.S. brands and sustained resilience in our core China operations. Margin Expansion: Gross profit marg

Ras Al Khaimah’s Strong Economic and Investment Environment Validated by Fitch Affirmation of ‘A+’ Credit Rating, With Stable Outlook15.5.2025 20:18:00 CEST | Press release

The positive rating reflects the Emirate’s strong long-term growth prospects and ongoing economic diversification Ras Al Khaimah’s strategic approach to sustainable, cross-sector growth and strong economic and investment environment has been validated by international credit rating agency Fitch, which reaffirmed the rating at ‘A+’ with a stable outlook. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515907689/en/ Ras Al Khaimah’s strong economic and investment environment validated by Fitch affirmation of ‘A+’ credit rating, with Stable Outlook (Photo: AETOSWire) Ras Al Khaimah Government welcomed the announcement as an endorsement of the Emirate’s resilient and expanding economy, sound fiscal management and the clear vision and unwavering commitment of its leadership to sustainable, long-term development and growth. The Emirate’s landmark tourism projects, including a major integrated resort, luxury hotels and world-clas

Cessna Citation CJ4 Gen3 Flight Test Program Advances Through Milestones as Second Test Article Takes Flight15.5.2025 20:00:00 CEST | Press release

Textron Aviation today announced a major program milestone for the Cessna Citation CJ4 Gen3 flight test program with the successful first flight of a second test article — P1. Testing on the P1 aircraft will focus on avionics, human factors and interiors. The Citation CJ4 Gen3 business jet is designed to keep pilots a step ahead in the cockpit by offering the next-generation Garmin G3000 PRIME avionics along with the most standard features in its class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515438856/en/ Cessna Citation CJ4 Gen3 flight test program advances through milestones as second test article takes flight. (Photo Credit: Textron Aviation) The Cessna Citation CJ4 Gen3 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. “This achievement continues the forward momentum of the CJ4 Gen3 program and reflects the dedication and expertise of our team in designing, certifying an

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye